Axillary lymph node and bone marrow micrometastases of breast cancer

被引:0
|
作者
Nahon, S [1 ]
Brewer, Y [1 ]
Kirscher, S [1 ]
Chauvet, B [1 ]
Berger, C [1 ]
Serin, D [1 ]
机构
[1] Inst St Catherine, F-84000 Avignon, France
关键词
breast cancer; micrometastase; prognostic;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Micrometastatic disease from breast cancer is a major concern both for clinicians and pathologists, Histologically, they can be defined as potentially invasive micro foci of tumoral cancer cells located in the vicinity of blood vessels and are a distinct entity from residual disease. They are mainly looked for in bone marrow and lymph nodes specimens and their diagnosis is currently easier thanks to immunohistochemistry. Provided tire a a standard definition of micrometastatic disease and standard screening procedures can be met, the presence of micrometastases at the time of diagnosis could represent major parameter in therapeutic decision-making. Although controversial the presence of medullary and axillary lymph node micrometastases appears to be a major prognostic factor in terms of survival. Recognition of this entity could help in better defining the high-risk subset of patients who would potentially benefit from adjuvant chemotherapy.
引用
收藏
页码:1095 / 1104
页数:10
相关论文
共 50 条
  • [1] Regional treatment for axillary lymph node micrometastases of breast cancer
    Houvenaeghel, G.
    Cohen, M.
    Jauffret-Fara, C.
    Bannier, M.
    Chereau-Ewald, E.
    Ribeiro, S. Rua
    Lambaudie, E.
    CANCER RADIOTHERAPIE, 2015, 19 (04): : 276 - 283
  • [2] The clinical significance of axillary lymph node micrometastases in breast cancer
    Sakorafas, GH
    Geraghty, J
    Pavlakis, C
    EJSO, 2004, 30 (08): : 807 - 816
  • [3] The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases
    Gipponi, M
    Canavese, G
    Lionetto, R
    Catturich, A
    Vecchio, C
    Sapino, A
    Friedman, D
    Cafiero, F
    EJSO, 2006, 32 (02): : 143 - 147
  • [4] Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients - Prognostic relevance after 10 years
    Gebauer, G
    Fehm, T
    Merkle, E
    Jaeger, W
    Mitze, M
    ANTICANCER RESEARCH, 2003, 23 (5B) : 4319 - 4324
  • [5] Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases
    Madeleine Hetterich
    Michael Gerken
    Olaf Ortmann
    Elisabeth C. Inwald
    Monika Klinkhammer-Schalke
    Holm Eggemann
    Atanas Ignatov
    Breast Cancer Research and Treatment, 2021, 187 : 715 - 727
  • [6] Clinical implications of axillary sentinel lymph node 'micrometastases' in breast cancer
    Krauth, J. -S.
    Charitansky, H.
    Isaac, S.
    Bobin, J. -Y.
    EJSO, 2006, 32 (04): : 400 - 404
  • [7] Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases
    Hetterich, Madeleine
    Gerken, Michael
    Ortmann, Olaf
    Inwald, Elisabeth C.
    Klinkhammer-Schalke, Monika
    Eggemann, Holm
    Ignatov, Atanas
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (03) : 715 - 727
  • [8] The prognostic significance of axillary lymph-node micrometastases in breast cancer patients
    Kuijt, GP
    Voogd, AC
    van de Poll-Franse, LV
    Scheijmans, LJEE
    van Beek, MWPM
    Roumen, RMH
    EJSO, 2005, 31 (05): : 500 - 505
  • [9] Axillary lymph node micrometastases decrease triple-negative early breast cancer survival
    G Houvenaeghel
    R Sabatier
    F Reyal
    J M Classe
    S Giard
    H Charitansky
    R Rouzier
    C Faure
    J R Garbay
    E Daraï
    D Hudry
    P Gimbergues
    R Villet
    E Lambaudie
    British Journal of Cancer, 2016, 115 : 1024 - 1031